| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.29 | 3e-07 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.27 | 1e-06 |